drugset / Trial / NCT00549120

Optimising the Propranolol Block Model

NCT00549120

Phase 1 Completed 18 enrolled GlaxoSmithKline
RandomizedCrossoverTriple-blindBasic science

Summary

Optimising the propranolol block model

Timeline

Start
2007-08-15
Primary completion
2007-10-26
Completion
2007-10-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Ipratropium Small molecule 40 ug Inhaled
Subject Propranolol Small molecule 80 mg
Subject Salbutamol Unknown 600 ug Inhaled